PointState Capital’s Qiagen QGEN Stock Holding History

PointState Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-94	Closed	-$5K	–	172
2021 Q2	$5K	Buy	+94	New	+$4.86K	﹤0.01%	126

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PointState Capital's QGEN Position: Q1 2022 in Review

PointState Capital sold out of Qiagen (QGEN) in Q1 2022, closing a stake of 169,750 shares — an estimated $10M sold.

PointState Capital first reported a position in QGEN in Q4 2019 and held it in 7 quarters. The position peaked at $25.9M in Q4 2019. 292 funds tracked by Wall St. Rank hold QGEN as of Q1 2022.

PointState Capital reported no remaining Qiagen position as of Q1 2022 after selling out during the quarter.
PointState Capital sold 169,750 Qiagen shares in Q1 2022, an estimated $10M.
PointState Capital first reported a position in Qiagen in Q4 2019 and held it in 7 quarters.
PointState Capital's Qiagen position peaked at $25.9M in Q4 2019.
292 funds tracked by Wall St. Rank held Qiagen as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.